Brief: Mayne Pharma Says 89.64% Shareholders At Scheme Meeting Voted In Favour Of Scheme Resolution
June 18 (Reuters) - Mayne Pharma MYX.AX: 89.64% OF CO SHAREHOLDERS PRESENT & VOTING AT SCHEME MEETING VOTED IN FAVOUR OF SCHEME RESOLUTION SCHEME RESOLUTION ON SCHEME OF ARRANGEMENT BETWEEN MAYNE PHARMA UNDER WHICH COSETTE PHARMACEUTICALS WILL ACQUIRE CO Further company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)